Thermo Fisher’s $9.4B Bet on Clinical Trial Digital Transformation
Life science giant Thermo Fisher Scientific makes a massive $9.4 billion move into clinical trial software. The acquisition of Clario represents a strategic pivot toward digital endpoints and AI-powered drug development analytics.